These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Determination of the molecular weight of microbial polysaccharides using high performance exclusion chromatography]. Chlenov MA; Iarovaia SM; Alekseeva GS; Kudriashov LI; Titova EV Prikl Biokhim Mikrobiol; 1987; 23(4):515-21. PubMed ID: 2443909 [TBL] [Abstract][Full Text] [Related]
4. Gel permeation chromatography of dextrans in parenteral solutions: calibration procedure development and method validation. Karmarkar S; Garber R; Kluza J; Koberda M J Pharm Biomed Anal; 2006 Jun; 41(4):1260-7. PubMed ID: 16650708 [TBL] [Abstract][Full Text] [Related]
5. [Determination of molecular weight distributions and mean molecular-weight values of clinical dextrans]. Basedow AM; Ebert KH Infusionsther Klin Ernahr; 1975 Aug; 2(4):261-5. PubMed ID: 1184177 [TBL] [Abstract][Full Text] [Related]
6. [Calibration of gel-chromatographic columns for examination of dextrans for clinical use]. Araco A; Frontali C Ann Ist Super Sanita; 1976; 12(4):289-94. PubMed ID: 1030603 [TBL] [Abstract][Full Text] [Related]
7. Molecular-weight distribution determination of clinical dextran by gel permeation chromatography. Nilsson G; Nilsson K J Chromatogr; 1974 Dec; 101(1):137-53. PubMed ID: 4443379 [No Abstract] [Full Text] [Related]
8. High-performance size-exclusion chromatographic procedure for the determination of fluoresceinyl isothiocyanate dextrans of various molecular masses in biological media. Kurtzhals P; Larsen C; Johansen M J Chromatogr; 1989 Jun; 491(1):117-27. PubMed ID: 2477386 [TBL] [Abstract][Full Text] [Related]
10. [Efficacy of plasma substitutes of different molecular weight in acute haemorrhagic shock in dogs (author's transl)]. Klose R; Hartung HJ; Ruffmann R; Lutz H Prakt Anaesth; 1979 Aug; 14(4):337-44. PubMed ID: 91161 [TBL] [Abstract][Full Text] [Related]
11. [Comparative analysis of thyroid extract gel filtration by dextran gel (Sephadex G-200) and agarose gel (Sepharose 6-B) (author's transl)]. Rosenthal D; Netto M; Da Silva MM; Fridman J Rev Bras Pesqui Med Biol; 1974; 7(1):37-44. PubMed ID: 4453640 [No Abstract] [Full Text] [Related]
12. [Qualities and application of macromolecular volume substitutes (author's transl)]. Seifart W Zentralbl Chir; 1977; 102(24):1473-83. PubMed ID: 74923 [TBL] [Abstract][Full Text] [Related]
13. Measurement and control of quality determining properties of clinical dextrans. Nilsson K Dev Biol Stand; 1980; 48():169-77. PubMed ID: 6168502 [TBL] [Abstract][Full Text] [Related]
14. [Further comments on a report of solution properties of dextran (author's transl)]. Kawahara K Yakugaku Zasshi; 1975 Dec; 95(12):1520-2. PubMed ID: 1240966 [No Abstract] [Full Text] [Related]
15. [Dextran-intolerance (author's transl)]. Misgeld V; Mende C Med Klin; 1974 Sep; 69(36):1452-5. PubMed ID: 4140461 [No Abstract] [Full Text] [Related]
16. An assessment of the potential use of anionic dextrans as a plasma substitute. Chang RL; Crawford MP; West MD J Biomed Eng; 1980 Jan; 2(1):41-4. PubMed ID: 7359897 [TBL] [Abstract][Full Text] [Related]
17. Analytical gel filtration of dextran for the study of the glomerular barrier function. Hagel L; Hartmann A; Lund K J Chromatogr; 1993 Jul; 641(1):63-70. PubMed ID: 7688752 [TBL] [Abstract][Full Text] [Related]
18. Fractionation of dextran and Ficoll by chromatography on Sephadex G-200. Laurent TC; Granath KA Biochim Biophys Acta; 1967 Mar; 136(2):191-8. PubMed ID: 6049492 [No Abstract] [Full Text] [Related]
19. [New aspects of shock therapy with volume expanders (author's transl)]. Landauer B; Krämer G MMW Munch Med Wochenschr; 1976 Apr; 118(18):553-8. PubMed ID: 58374 [TBL] [Abstract][Full Text] [Related]
20. [Physico-chemical characteristics of various plasma substitutes]. Granath K; Strömberg R Minerva Anestesiol; 1968 Nov; 34(11):1300-11. PubMed ID: 5715827 [No Abstract] [Full Text] [Related] [Next] [New Search]